Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ANTINEOPLASTIC AGENTS - THERAPEUTIC USE , . Treffer: 211

2022

Lyon, AR; López-Fernández, T; Couch, LS; Asteggiano, R; Aznar, MC; Bergler-Klein, J; Boriani, G; Cardinale, D; Cordoba, R; Cosyns, B; Cutter, DJ; de, Azambuja, E; de Boer, RA; Dent, SF; Farmakis, D; Gevaert, SA; Gorog, DA; Herrmann, J; Lenihan, D; Moslehi, J; Moura, B; Salinger, SS; Stephens, R; Suter, TM; Szmit, S; Tamargo, J; Thavendiranathan, P; Tocchetti, CG; van der Meer, P; van der Pal, HJH; ESC Scientific Document Group 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Eur Heart J Cardiovasc Imaging. 2022; 23(10): e333-e465. Doi: 10.1093/ehjci/jeac106
PubMed FullText FullText_MUG

 

Wirth, AK; Wange, L; Vosberg, S; Henrich, KO; Rausch, C; Özdemir, E; Zeller, CM; Richter, D; Feuchtinger, T; Kaller, M; Hermeking, H; Greif, PA; Senft, D; Jurinovic, V; Bahrami, E; Jayavelu, AK; Westermann, F; Mann, M; Enard, W; Herold, T; Jeremias, I In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Leukemia. 2022; 36(12):2863-2874 Doi: 10.1038/s41375-022-01726-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Conforti, C; Toffoli, L; Agozzino, M; Di, Meo, N; Zelin, E; Zalaudek, I Dermatoscopy and locally advanced or multiple basal cell carcinomas: a non-invasive tool to evaluate sonidegib effectiveness.
Dermatol Online J. 2021; 27(9): Doi: 10.5070/D327955150 (- Case Report)
PubMed FullText FullText_MUG

 

2020

Conforti, C; Giuffrida, R; Di, Meo, N; Zalaudek, I Management of locally advanced basal cell carcinoma treated with sonidegib: The experience of an Italian reference hospital.
Dermatol Ther. 2020; 33(6): e14511 Doi: 10.1111/dth.14511
Web of Science PubMed FullText FullText_MUG

 

2019

Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Steiger, K; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol. 2019; 102(5):437-441 Doi: 10.1111/ejh.13218 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedmann, K; Bassermann, F; Jost, PJ [Kinase inhibitors in oncology : What is new?]
Internist (Berl). 2019; 60(5):540-544 Doi: 10.1007/s00108-019-0577-8
Web of Science PubMed FullText FullText_MUG

 

Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498 Doi: 10.1097/RCT.0000000000000848
Web of Science PubMed FullText FullText_MUG

 

Vujic, J; Schöllnast, H; Marsoner, K; Wienerroither, V; Bacher, H; Mischinger, HJ; Kornprat, P Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
Anticancer Res. 2019; 39(7):3847-3854 Doi: 10.21873/anticanres.13534 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Hann, A; Nosalski, E; Hermann, PC; Egger, J; Seufferlein, T; Keller, F Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Clin Nephrol. 2018; 90(2):125-141 Doi: 10.5414/CN109327
Web of Science PubMed FullText FullText_MUG

 

2017

Berry, V; Basson, L; Bogart, E; Mir, O; Blay, JY; Italiano, A; Bertucci, F; Chevreau, C; Clisant-Delaine, S; Liegl-Antzager, B; Tresch-Bruneel, E; Wallet, J; Taieb, S; Decoupigny, E; Le Cesne, A; Brodowicz, T; Penel, N REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
Cancer. 2017; 123(12):2294-2302 Doi: 10.1002/cncr.30661 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dirschka, T; Gupta, G; Micali, G; Stockfleth, E; Basset-Séguin, N; Del Marmol, V; Dummer, R; Jemec, GBE; Malvehy, J; Peris, K; Puig, S; Stratigos, AJ; Zalaudek, I; Pellacani, G Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.
J Dermatolog Treat. 2017; 28(5):431-442 Doi: 10.1080/09546634.2016.1254328 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Goblirsch, M; Richtig, G; Slaby, O; Berindan-Neagoe, I; Gerger, A; Pichler, M MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
Pharmacogenomics. 2017; 18(10):1027-1038 Doi: 10.2217/pgs-2017-0004
Web of Science PubMed FullText FullText_MUG

 

Lohberger, B; Stuendl, N; Leithner, A; Rinner, B; Sauer, S; Kashofer, K; Liegl-Atzwanger, B Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Sci Rep. 2017; 7(9):44700-44700 Doi: 10.1038/srep44700 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mayr, C; Ocker, M; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T Biliary tract cancer stem cells - translational options and challenges.
World J Gastroenterol. 2017; 23(14):2470-2482 Doi: 10.3748/wjg.v23.i14.2470 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mynarek, M; Pizer, B; Dufour, C; van Vuurden, D; Garami, M; Massimino, M; Fangusaro, J; Davidson, T; Gil-da-Costa, MJ; Sterba, J; Benesch, M; Gerber, N; Juhnke, BO; Kwiecien, R; Pietsch, T; Kool, M; Clifford, S; Ellison, DW; Giangaspero, F; Wesseling, P; Gilles, F; Gottardo, N; Finlay, JL; Rutkowski, S; von Hoff, K Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.
Neuro Oncol. 2017; 19(4):576-585 Doi: 10.1093/neuonc/now234 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schanza, LM; Seles, M; Stotz, M; Fosselteder, J; Hutterer, GC; Pichler, M; Stiegelbauer, V MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(11): Doi: 10.3390/ijms18112495 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71 Doi: 10.1111/bjh.14637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Urech, M; Kyrgidis, A; Argenziano, G; Reggiani, C; Moscarella, E; Longo, C; Alfano, R; Zalaudek, I; Lallas, A Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study.
Acta Derm Venereol. 2017; 97(1):117-119 Doi: 10.2340/00015555-2464 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Boehnke, K; Iversen, PW; Schumacher, D; Lallena, MJ; Haro, R; Amat, J; Haybaeck, J; Liebs, S; Lange, M; Schäfer, R; Regenbrecht, CR; Reinhard, C; Velasco, JA Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
J Biomol Screen. 2016; 21(9):931-941 Doi: 10.1177/1087057116650965 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

 

Grillo, F; Fassan, M; Sarocchi, F; Fiocca, R; Mastracci, L HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.
World J Gastroenterol. 2016; 22(26): 5879-5887. Doi: 10.3748/wjg.v22.i26.5879 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

He, JC; Yao, W; Wang, JM; Schemmer, P; Yang, Y; Liu, Y; Qian, YW; Qi, WP; Zhang, J; Shen, Q; Yang, T TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
Oncotarget. 2016; 7(46):75441-75456 Doi: 10.18632/oncotarget.12254 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ignatiadis, M; Rack, B; Rothé, F; Riethdorf, S; Decraene, C; Bonnefoi, H; Dittrich, C; Messina, C; Beauvois, M; Trapp, E; Goulioti, T; Tryfonidis, K; Pantel, K; Repollet, M; Janni, W; Piccart, M; Sotiriou, C; Litiere, S; Pierga, JY Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.
Eur J Cancer. 2016; 63(10):97-104 Doi: 10.1016/j.ejca.2016.04.024
Web of Science PubMed FullText FullText_MUG

 

Lee, SB; Weide, B; Ugurel, S; Mössner, R; Enk, A; Hassel, JC Vemurafenib-induced granuloma annulare.
J Dtsch Dermatol Ges. 2016; 14(3):305-308 Doi: 10.1111/ddg.12777 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

 

Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, S; Thurnher, D; Kadletz, L; Seemann, R; Brunner, M; Kotowski, U; Schmid, R; Lill, C; Heiduschka, G Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
Oral Dis. 2016; 22(8):797-804 Doi: 10.1111/odi.12552
Web of Science PubMed FullText FullText_MUG

 

Shafirstein, G; Battoo, A; Harris, K; Baumann, H; Gollnick, SO; Lindenmann, J; Nwogu, CE Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions.
Ann Am Thorac Soc. 2016; 13(2):265-275 Doi: 10.1513/AnnalsATS.201509-650FR [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zhang, F; Li, M; Wang, J; Liang, X; Su, Y; Wang, W Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs.
AAPS PharmSciTech. 2016; 17(3):539-552 Doi: 10.1208/s12249-016-0518-y
Web of Science PubMed FullText FullText_MUG

 

2015

Andreou, D; Werner, M; Pink, D; Traub, F; Schuler, M; Gosheger, G; Jobke, B; Reichardt, P; Tunn, PU Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Br J Cancer. 2015; 112(3): 455-60. Doi: 10.1038/bjc.2014.635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Aufderklamm, S; Todenhöfer, T; Hennenlotter, J; Mischinger, J; Sim, A; Böttge, J; Rausch, S; Bier, S; Halalsheh, O; Stenzl, A; Gakis, G; Schwentner, C Complex residual tumors after chemotherapy of nonseminomatous germ cell tumors. Laparoscopic management - limits and chances].
Urologe A. 2015; 54(7):1002-1009 Doi: 10.1007/s00120-014-3616-z
Web of Science PubMed FullText FullText_MUG

 

Bochis, OV; Irimie, A; Pichler, M; Berindan-Neagoe, I The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
J Gastrointestin Liver Dis. 2015; 24(2):225-234 Doi: 10.15403/jgld.2014.1121.242.skp2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Datar, RH; Balic, M; Cote, RJ Circulating Tumor Cells: Where From Here?
Semin Oncol. 2015; 42(4):515-517 Doi: 10.1053/j.seminoncol.2015.05.010
Web of Science PubMed FullText FullText_MUG

 

Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 Doi: 10.1136/jclinpath-2015-202996 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fröhlich, E; Wahl, R Chemotherapy and chemoprevention by thiazolidinediones.
Biomed Res Int. 2015; 2015(3):845340-845340 Doi: 10.1155/2015/845340 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hecimovic, A; Jakopovic, M; Pavlisa, G; Jankovic, M; Vukic-Dugac, A; Redzepi, G; Brcic, L; Samarzija, M; Gupta, N SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
Lymphology. 2015; 48(2):97-102
Web of Science PubMed

 

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 Doi: 10.1186/s12885-015-1373-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Sinn, B; Hatzis, C; Albarracin, C; Downs-Kelly, E; Morkowski, J; Gould, R; Symmans, WF Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
MODERN PATHOL. 2015; 28(7): 913-920. Doi: 10.1038/modpathol.2015.53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 Doi: 10.1056/NEJMoa1503093 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

Takaori, K; Bassi, C; Biankin, A; Brunner, TB; Cataldo, I; Campbell, F; Cunningham, D; Falconi, M; Frampton, AE; Furuse, J; Giovannini, M; Jackson, R; Nakamura, A; Nealon, W; Neoptolemos, JP; Real, FX; Scarpa, A; Sclafani, F; Windsor, JA; Yamaguchi, K; Wolfgang, C; Johnson, CD, , IAP/EPC, study, group, on, the, clinical, managements, of, pancreatic, cancer International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.
Pancreatology. 2015; 16(1):14-27 Doi: 10.1016/j.pan.2015.10.013
Web of Science PubMed FullText FullText_MUG

 

Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095 Doi: 10.3390/ijms160818077 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wenzl, K; Troppan, K; Neumeister, P; Deutsch, AJ The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Curr Drug Targets. 2015; 16(1):38-46 Doi: 10.2174/1389450115666141120112818
Web of Science PubMed FullText FullText_MUG

 

Widschwendter, P; Friedl, TW; Schwentner, L; DeGregorio, N; Jaeger, B; Schramm, A; Bekes, I; Deniz, M; Lato, K; Weissenbacher, T; Kost, B; Andergassen, U; Jueckstock, J; Neugebauer, J; Trapp, E; Fasching, PA; Beckmann, MW; Schneeweiss, A; Schrader, I; Rack, B; Janni, W; Scholz, C The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Breast Cancer Res. 2015; 17(4):129-129 Doi: 10.1186/s13058-015-0639-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Benesch, M; Bartelheim, K; Fleischhack, G; Gruhn, B; Schlegel, PG; Witt, O; Stachel, KD; Hauch, H; Urban, C; Quehenberger, F; Massimino, M; Pietsch, T; Hasselblatt, M; Giangaspero, F; Kordes, U; Schneppenheim, R; Hauser, P; Klingebiel, T; Frühwald, MC High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).
Bone Marrow Transplant. 2014; 49(3):370-375 Doi: 10.1038/bmt.2013.208 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853 Doi: 10.1097/CAD.0000000000000108
Web of Science PubMed FullText FullText_MUG

 

Buder, K; Müller, PA; Beckmann, G; Ugurel, S; Bröcker, EB; Becker, JC Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
Acta Derm Venereol. 2014; 94(1):94-96 Doi: 10.2340/00015555-1627 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cramer, L; Hildebrandt, B; Kung, T; Wichmann, K; Springer, J; Doehner, W; Sandek, A; Valentova, M; Stojakovic, T; Scharnagl, H; Riess, H; Anker, SD; von Haehling, S Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer.
J Am Coll Cardiol. 2014; 64(13):1310-1319 Doi: 10.1016/j.jacc.2014.07.948 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ding, X; Wang, W; Wang, Y; Bao, X; Wang, Y; Wang, C; Chen, J; Zhang, F; Zhou, J Versatile reticular polyethylenimine derivative-mediated targeted drug and gene codelivery for tumor therapy.
Mol Pharm. 2014; 11(10):3307-3321 Doi: 10.1021/mp5001263
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum